Why the study?
Long-COVID-19 syndrome presents with autonomic dysfunction and exercise intolerance, but the relationship between exercise capacity-mediated disruption of the autonomic nervous system and long-COVID-19 symptoms needed investigation.
Does long-COVID-19 syndrome alter heart rate variability and is this effect mediated by cardiorespiratory fitness compared to healthy controls?
Does long-COVID-19 syndrome alter heart rate variability and is this effect mediated by cardiorespiratory fitness compared to healthy controls?
Dysautonomia in long COVID-19 patients is characterized by reduced heart rate variability and is partially mediated by low cardiorespiratory fitness.
Indicates possible fitness-mediated dysautonomia in long COVID; hypothesis-generating for interventions pending longitudinal data.
Long‐COVID-19 syndrome (LCS) exhibits neurological problems such as peripheral neuropathy and autonomic nervous system (ANS) dysfunction. Exercise intolerance and, consequently, low cardiorespiratory fitness (CRF) are some of the most common symptoms of LCS. We describe a series of individuals exhibiting LCS symptoms compared to a control group and posit that this condition may be related to the exercise capacity–mediated disruption of the ANS resulting particularly in exercise intolerance. This study included 87 individuals with LCS and 71 control participants without COVID-19 diagnoses. Heart rate variability (HRV) in supine position is commonly measured to diagnose autonomic dysregulation and subsequently analyzed using the Kubios software (Kuopio, Finland). CRF (peak VO2), post-COVID-19 patient-reported symptoms, maximal muscle strength (grip strength, bilateral leg press, leg extension, pectoral press, and back press exercises), and body composition were also measured. Analysis of covariance (ANCOVA) and mediation analysis were employed to assess the associations among LCS, peak VO2, and HRV indicators. Two-sided p < 0.05 was considered as significant. The HRV parameters—RR interval, RMSSD, SDNN, PNS index, LF, HF, total power, SD1, and SD2—were significantly elevated (p < 0.05) in the control group when compared to the LCS patients. In contrast, the HR, stress index, and SNS index parameters were significantly higher (p < 0.05) in the LCS group. When adjusted for RR intervals, these parameters remained statistically significant (p < 0.05). A partially mediated effect was found between peak VO2 and RMSSD (mediation effect = 24.4%) as well as peak VO2 and SDNN (mediation effect = 25.1%) in the LCS patients. These findings contribute new insights on the interplay between CRF and HRV indicators as well as endorse that dysautonomia may be related to the low peak VO2 observed in long COVID-19 patients.
No takes yet. Share an insight, caveat, or question.
Oscoz-Ochandorena et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: